Akorn Inc (AKRX.OQ)
21 Apr 2017
Latest Key Developments (Source: Significant Developments)
Akorn Inc: Q4 gaap earnings per share $0.26 . expects 2017 adjusted net income per diluted share (non-gaap) $1.53 - $1.72 . Akorn provides fourth quarter and full year 2016 results and outlines full year 2017 guidance . Q4 revenue $284 million versus i/b/e/s view $288 million . Q4 earnings per share view $0.57 -- Thomson Reuters I/B/E/S . Q4 adjusted non-gaap earnings per share $0.58 including items . sees 2017 consolidated revenue, $ 1,010 million- $ 1,060 million . Akorn's guidance includes $30 to $60 million from new product launches of products already approved and those expected to be approved in 2017 . sees 2017 gaap net income per diluted share $0.99 -$1.18 . sees 2017 adjusted net income per diluted share (non-gaap) $1.53- $1.72 .Fy2017 earnings per share view $2.17, revenue view $1.12 billion -- Thomson Reuters I/B/E/S. Full Article
Akorn, Inc:Says Duane A. Portwood, will join Akorn as Executive Vice President and Chief Financial Officer, effective October 30, 2015.Interim Chief Financial Officer Randall Pollard will continue to serve as Senior Vice President, Chief Accounting Officer and Corporate Controller after Portwood's appointment. Full Article
Akorn Inc:Says It has launched Doxercalciferol Injection Solution, 4 mcg/2 mL in 2mL single-use vials. The launch follows an approval of an abbreviated new drug application for the product from the U.S. Food and Drug Administration on May 7, 2015. Full Article
Akorn Inc:Announced the appointment of Randall Pollard as Chief Accounting Officer and Interim Chief Financial Officer.Pollard's appointment follows the departure of Timothy Dick, who has elected to step down as Senior Vice President and Chief Financial Officer to pursue other opportunities. Full Article
Generic drugmaker Akorn Inc must pay $20.5 million in a lawsuit by a Georgia teacher who accused the company of failing to warn that one of its products would react adversely with another medication she was already taking, a state court jury has ruled.